Journal of the Neurological Sciences
Volume 296, Issue 1 , Pages 1-6, 15 September 2010

Why mesial temporal lobe epilepsy with hippocampal sclerosis is progressive: Uncontrolled inflammation drives disease progression?

  • Tianhua Yang

      Affiliations

    • Department of Neurology, West China Hospital, Si Chuan University, Cheng du, Sichuan, China
  • ,
  • Dong Zhou

      Affiliations

    • Department of Neurology, West China Hospital, Si Chuan University, Cheng du, Sichuan, China
    • Corresponding Author InformationCorresponding author. Department of Neurology, West China Hospital, Sichuan University, 610041 Chengdu, Sichuan, China. Tel.: +86 13980008088; fax: +86 28 85423550.
  • ,
  • Hermann Stefan

      Affiliations

    • Department of Neurology, Center of Epilepsy (ZEE), University of Erlangen-Nuremberg, Erlangen, Germany

Received 12 January 2010; received in revised form 28 May 2010; accepted 2 June 2010. published online 21 July 2010.

Abstract 

Mesial temporal lobe epilepsy with hippocampal sclerosis (MTLE-HS) is a group of chronic disorders characterized by prominent neuronal loss and gliosis in the hippocampus and amygdala. Newly published data indicate that it may be a progressive disease, but the mechanism underlying the progressive nature remains unknown. Recently, substantial evidence for an inflammatory mechanism in MTLE has been documented. We are therefore presenting a review of literature concerning the effects of uncontrolled inflammation on the disease progression of MTLE-HS. We found that increasing amounts of evidence support the association between uncontrolled inflammation and progression of the disease. Uncontrolled inflammatory processes may be a main mechanism underlying the self-propagating cycle of uncontrolled inflammation, blood-brain barrier damage, and seizures that drive the progressive nature. Thus it is important to unravel the principles of communication between the different factors in this cycle. The dynamic modulation of inflammatory processes aimed at preventing or interrupting this cycle has the potential to emerge as a novel therapeutic strategy. This line of therapy might offer new perspectives on the pharmacologic treatment of seizures, and possibly on delaying disease progression or retarding epileptogenesis as well.

Keywords: Mesial temporal lobe epilepsy, Inflammation, Seizure

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0022-510X(10)00250-9

doi:10.1016/j.jns.2010.06.002

Journal of the Neurological Sciences
Volume 296, Issue 1 , Pages 1-6, 15 September 2010